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Smoking is the world’s leading cause of preventable illness 
and death (1). Accounting for 6 million deaths annually, 
600,000 of smoking-related deaths occur in non-smokers 
exposed to second hand smoke (2). A major risk factor for 
six of the eight leading causes of death worldwide, smoking 
affects nearly every organ of the body (3). Smokers usually 
underestimate their risk of smoking-related diseases (4). 
Awareness of health concerns are a major motivator to 
quit (5,6). One in every two smokers will die from their 
addiction, however quitting substantially reduces this 
risk (7,8). Making an attempt to quit smoking and then 
sustaining abstinence are both equally important in 
ultimately succeeding quitting. Smokers frequently attempt 
quitting several times unsuccessfully before achieving 
long-term abstinence (9,10). Smokers who seek support in 
quitting are much more likely to quit than those who try to 
quit alone, and the most effective aid for achieving smoking 
cessation is medication (e.g., nicotine replacement therapy, 
or varenicline) coupled with tailored behavioral support 
from specialist stop smoking services, like the National 
Health Service Stop Smoking Services (NHS SSS) in the 
UK (11-13).
NHS SSS encourage and support smokers to quit 
smoking. Providing specialist advice and access to 
medication support, this comprehensive program has seen a 
good success rate in their reach and impact (14). However, 
despite achieving quit rates of 35% in 4 weeks of using the 
program, less than 5% of the smokers actually utilize the 
service owing to declined motivation to contact the services 
after referral from health care providers (14-16).
The lack of motivation to utilise this free service offered 
by NHS which otherwise has reported a good smoking 
cessation rate has been a thought to much more research 
in recent times. Some published studies have found that 
communicating tailored messages positively impacts 
recruitment and engagement, increasing the uptake and 
referral to these services (17). Proactive engagement of 
smokers by personalizing the advice and communicating 
the risk factors tailored to the individual works as a good 
engagement strategy. Additionally, targeting the smokers, 
who might be unaware of the smoking cessation program 
or may have inadequate information, can help motivate 
them to join a ‘free trial session’; to ‘come and try out’ and 
experience the service. Gilbert et al. assessed this multimodal 
approach in the Start2quit trial conducted across 18 SSS 
comprising of 99 general practices in England (18). The 
uptake of SSS program was assessed by sending a tailored 
letter communicating risk to the individual smoker along 
with a ‘no-commitment’ trial session of the SSS program 
(intervention arm) compared to usual practice of sending a 
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generic letter informing about the SSS. 
A total of 4,383 smokers were enrolled and followed up 
for 6 months to ascertain the attendance in the first SSS 
course and their smoking status. The proportion of smokers 
attending the first session of SSS course were significantly 
higher in the intervention group [17.4% (n=458)] compared 
to the control group [9.0% (n=158)]; [odds ratio (OR) 
=2.12; [95% confidence interval (CI), 1.75–2.57]; P<0·0001}. 
The number of participants reporting 7-day point-prevalent 
abstinence was higher in the intervention group [9.0% 
(n=236)] compared to the control group [5.6% (n=97)]; 
[OR =1.68; (95% CI, 1.32–2.15); P<0·0001]. Around half 
of the intervention group participants who attended the 
trial session came back for the SSS course. Number of 
participants achieving 7-day abstinence was higher for ones 
attending both the trial session and the SSS course [28.7% 
(97 of 338] compared to those who only attended either the 
trial session [10.0% (40 of 401)], or the SSS course [17.5% 
(21 of 120)]. We further calculated the risk difference per 
100 smokers treated for the outcome of validated 7-day 
point-prevalence abstinence which indicated that for every 
100 patients receiving the intervention, 3.4 (95% CI, 
1.9–4.9) additional patients would quit compared to 100 
patients allocated to the control group. 
The acceptance of both the communication of personal 
risk letter and the trial session augments the general 
acceptance of this proactive identification and intensive 
engagement strategy. The two components of the 
intervention might work additively or a personal advice 
tailored to an individual from health care professional might 
trigger cues to action. A ‘try-out’ session without the need 
of any commitment might serve as a laxer approach, giving 
an opportunity to experience the service. As opposed to 
the traditional smoking cessation programs, which target 
smoking population having an intention and motivation 
to quit, the program substantiates the need to proactively 
engage all the smokers even with unclear or distant plans to 
quit smoking. This could prove to be an effective approach 
in triggering the motivation to quit (19).
Being the first study to assess the effectiveness of using 
‘come and try’ sessions to motivate people to join smoking 
cessation services, the findings demonstrate potential in 
reaching and engaging larger populations. The individual 
effectiveness of both the component of the intervention—
tailored risk communication or the trial session would be 
interesting to investigate further. Adopting and closely 
integrating technological interventions such as mHealth, 
eHealth, and eLearning into this strategy could further 
assist in follow-up and data collection. This could further 
accentuate the population imbibition in a cost and time 
effective manner (20). The cost-effectiveness analysis of the 
interventions which is to be published in the near future 
would be interesting too for real-world implementation. 
The program as a whole offers very promising and novel 
avenues to derive benefit from the existing smoking 
cessation services and may be applicable to other health 
promotion services.
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